Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

172.45
+2.291.34%
Volume:2.70M
Turnover:467.62M
Market Cap:305.05B
PE:72.15
High:174.66
Open:171.08
Low:170.91
Close:170.16
Loading ...

From Rookie Mistakes To $10K/Year In Dividends – Military Veteran Who 'Made A Few Great Plays' Shares His 10 Biggest Bets

Benzinga
·
27 Mar

AbbVie Inc. (ABBV) is Attracting Investor Attention: Here is What You Should Know

Zacks
·
27 Mar

VKTX Finishes Enrolment in Mid-Stage Study on Oral Weight-Loss Drug

Zacks
·
27 Mar

CollPlant Biotechnologies Ltd (CLGN) Q4 2024 Earnings Call Highlights: Navigating Revenue ...

GuruFocus.com
·
27 Mar

AbbVie (NYSE:ABBV) Showcases Oncology Innovations Amidst 6% Share Price Dip

Simply Wall St.
·
27 Mar

AbbVie Showcases Early Pipeline and Scientific Advances in Oncology at AACR Annual Meeting 2025

PR Newswire
·
26 Mar

These Dividend Aristocrats' Stocks Can Protect You From the Market Selloff -- Barrons.com

Dow Jones
·
26 Mar

AbbVie (ABBV) Stock Sinks As Market Gains: Here's Why

Zacks
·
25 Mar

BRIEF-Abbvie CEO Robert A. Michael's 2024 Total Compensation Was $18.5 Million - Filing

Reuters
·
25 Mar

Abbvie: Executive Chairman Richard a. Gonzalez's 2024 Total Compensation Was $28.5 Mln - Filing

THOMSON REUTERS
·
25 Mar

Sector Update: Health Care Stocks Edge Higher Premarket Monday

MT Newswires Live
·
24 Mar

Genmab Denies Trade Secret Misappropriation Claims by AbbVie

MT Newswires Live
·
24 Mar

Q4 Rundown: Moderna (NASDAQ:MRNA) Vs Other Therapeutics Stocks

StockStory
·
24 Mar

Allergan Aesthetics Emphasizes Commitment to Innovation, Science and a Patient Centric Approach at AMWC 2025

PR Newswire
·
24 Mar

Nvidia, Exxon, AbbVie, Uber, Adobe: Insider Moves Unveiled

TIPRANKS
·
22 Mar

BRIEF-Genmab To Vigorously Defend Alleged Claims Of Trade Secret Misappropriation By Abbvie Inc.

Reuters
·
22 Mar

Genmab to Vigorously Defend Alleged Claims of Trade Secret Misappropriation by AbbVie Inc.

GlobeNewswire
·
22 Mar

Here's How Many Shares of AbbVie You Need to Own to Get $1,000 in Yearly Dividends

Motley Fool
·
20 Mar

AbbVie (ABBV) Stock Moves -0.29%: What You Should Know

Zacks
·
19 Mar

AbbVie put volume heavy and directionally bearish

TIPRANKS
·
18 Mar